140 related articles for article (PubMed ID: 22466963)
1. Electrophysiological effects of the class Ic antiarrhythmic drug pilsicainide on the guinea-pig pulmonary vein myocardium.
Takahara A; Takeda K; Tsuneoka Y; Hagiwara M; Namekata I; Tanaka H
J Pharmacol Sci; 2012; 118(4):506-11. PubMed ID: 22466963
[TBL] [Abstract][Full Text] [Related]
2. Electrophysiological effects of the antiarrhythmic drug bepridil on the guinea-pig pulmonary vein myocardium.
Takahara A; Takeda K; Hagiwara M; Tanaka H
Biol Pharm Bull; 2013; 36(2):311-5. PubMed ID: 23370360
[TBL] [Abstract][Full Text] [Related]
3. Electrophysiological effects of an anti-influenza drug oseltamivir on the guinea-pig atrium: comparison with those of pilsicainide.
Takahara A; Suzuki S; Hagiwara M; Nozaki S; Sugiyama A
Biol Pharm Bull; 2013; 36(10):1650-2. PubMed ID: 24088258
[TBL] [Abstract][Full Text] [Related]
4. Effect of pilsicainide on dominant frequency in the right and left atria and pulmonary veins during atrial fibrillation: association with its atrial fibrillation terminating effect.
Horiuchi D; Iwasa A; Sasaki K; Owada S; Kimura M; Sasaki S; Okumura K
Eur J Pharmacol; 2009 Apr; 608(1-3):54-61. PubMed ID: 19268659
[TBL] [Abstract][Full Text] [Related]
5. Electrophysiological and pharmacological characteristics of triggered activity elicited in guinea-pig pulmonary vein myocardium.
Takahara A; Sugimoto T; Kitamura T; Takeda K; Tsuneoka Y; Namekata I; Tanaka H
J Pharmacol Sci; 2011; 115(2):176-81. PubMed ID: 21258174
[TBL] [Abstract][Full Text] [Related]
6. Pilsicainide for atrial fibrillation.
Kumagai K; Nakashima H; Tojo H; Yasuda T; Noguchi H; Matsumoto N; Ogawa M; Saku K
Drugs; 2006; 66(16):2067-73. PubMed ID: 17112301
[TBL] [Abstract][Full Text] [Related]
7. Effects of pilsicainide on the atrial fibrillation threshold in guinea pig atria. A comparative study with disopyramide, lidocaine and flecainide.
Inoue M; Inoue D; Ishibashi K; Sakai R; Omori I; Yamahara Y; Asayama J; Nakagawa M
Jpn Heart J; 1993 May; 34(3):301-12. PubMed ID: 8411636
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary vein myocardium as a possible pharmacological target for the treatment of atrial fibrillation.
Takahara A; Hagiwara M; Namekata I; Tanaka H
J Pharmacol Sci; 2014; 126(1):1-7. PubMed ID: 25242082
[TBL] [Abstract][Full Text] [Related]
9. Hybrid therapy with pilsicainide and pulmonary vein isolation for atrial fibrillation.
Tojo H; Kumagai K; Noguchi H; Ogawa M; Yasuda T; Nakashima H; Zhang B; Miura S; Saku K
Circ J; 2005 Dec; 69(12):1503-7. PubMed ID: 16308499
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of the preventive effect of pilsicainide on atrial fibrillation originating from the pulmonary vein.
Hirose M; Ohkubo Y; Takano M; Hamazaki M; Sekido T; Yamada M
Circ J; 2007 Nov; 71(11):1805-14. PubMed ID: 17965507
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of the electrophysiological effects on the atrial myocardium between the pure Na channel blocker, pilsicainide, and flecainide.
Kanemoto M; Shimizu A; Yamagata T; Esato M; Ueyama T; Yoshiga Y; Kakugawa H; Kametani R; Inoue N; Sawa A; Matsuzaki M
Cardiovasc Drugs Ther; 2004 Jul; 18(4):295-303. PubMed ID: 15367827
[TBL] [Abstract][Full Text] [Related]
12. Cardiohemodynamic and electrophysiological effects of anti-influenza drug oseltamivir in vivo and in vitro.
Kitahara K; Nakamura Y; Tsuneoka Y; Adachi-Akahane S; Tanaka H; Yamazaki H; Takahara A; Yamazaki J; Ikeda T; Sugiyama A
Cardiovasc Toxicol; 2013 Sep; 13(3):234-43. PubMed ID: 23420508
[TBL] [Abstract][Full Text] [Related]
13. Uniqueness of pilsicainide in class Ic antiarrhythmics.
Yamashita T; Murakawa Y; Sezaki K; Hayami N; Inoue M; Fukui E; Omata M
Jpn Heart J; 1998 May; 39(3):389-97. PubMed ID: 9711190
[TBL] [Abstract][Full Text] [Related]
14. Effects of pilsicainide and propafenone on vagally induced atrial fibrillation: role of suppressant effect in conductivity.
Iwasa A; Okumura K; Tabuchi T; Tsuchiya T; Tsunoda R; Matsunaga T; Tayama S; Yasue H
Eur J Pharmacol; 1998 Aug; 356(1):31-40. PubMed ID: 9761421
[TBL] [Abstract][Full Text] [Related]
15. Electropharmacologic effects of pilsicainide, a pure sodium channel blocker, on the remodeled atrium subjected to chronic rapid pacing.
Sato T; Mitamura H; Kurita Y; Takeshita A; Shinagawa K; Miyoshi S; Kanki H; Hara M; Ogawa S
J Cardiovasc Pharmacol; 2001 Dec; 38(6):812-20. PubMed ID: 11707684
[TBL] [Abstract][Full Text] [Related]
16. Electrophysiological and Pharmacological Characteristics of Triggered Activity Elicited in Guinea-Pig Pulmonary Vein Myocardium.
Takahara A; Sugimoto T; Kitamura T; Takeda K; Tsuneoka Y; Namekata I; Tanaka H
J Pharmacol Sci; 2011; 115(2):176-181. PubMed ID: 32272535
[TBL] [Abstract][Full Text] [Related]
17. Effect of pilsicainide on atrial electrophysiologic properties in the canine rapid atrial stimulation model.
Kojima J; Niwano S; Moriguchi M; Ikeda K; Inuo K; Saito J; Izumi T
Circ J; 2003 Apr; 67(4):340-6. PubMed ID: 12655166
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiological effects of sodium channel blockers on guinea pig left atrium.
Shirayama T; Inoue D; Inoue M; Tatsumi T; Yamahara Y; Asayama J; Katsume H; Nakagawa M
J Pharmacol Exp Ther; 1991 Nov; 259(2):884-93. PubMed ID: 1658312
[TBL] [Abstract][Full Text] [Related]
19. Determination of refractory periods and conduction velocity during atrial fibrillation using atrial capture in dogs: direct assessment of the wavelength and its modulation by a sodium channel blocker, pilsicainide.
Shinagawa K; Mitamura H; Takeshita A; Sato T; Kanki H; Takatsuki S; Ogawa S
J Am Coll Cardiol; 2000 Jan; 35(1):246-53. PubMed ID: 10636287
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of class I antiarrhythmic drugs on the guinea pig pulmonary vein myocardium: Inhibition of automatic activity correlates with blockade of a diastolic sodium current component.
Irie M; Hiiro H; Kato S; Kuramochi M; Hamaguchi S; Namekata I; Tanaka H
J Pharmacol Sci; 2020 Aug; 143(4):325-329. PubMed ID: 32487451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
